Published: Jun 15, 2026
Written by Klarity Editorial Team
Published: Jun 15, 2026

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe medications via telehealth in 2026 — and more importantly, how to do it profitably and compliantly — you’re in the right place.
The short answer: Yes, psychiatrists can prescribe nearly all psychiatric medications through telehealth in 2026, including controlled substances like Adderall, Xanax, and Suboxone. But the rules vary significantly by state, and the difference between an MD and a PMHNP’s authority can be night and day depending on where your patient is sitting.
Let’s break down what you can actually do, where the regulations still trip people up, and how the economics of telehealth prescribing compare to traditional patient acquisition methods.
As a fully licensed physician, a psychiatrist has unrestricted prescribing authority in all 50 states — as long as you’re licensed where the patient is located. That includes:
The key regulatory question isn’t what you can prescribe — it’s whether you can initiate controlled substances without an in-person visit.
Under normal circumstances, the Ryan Haight Act requires at least one in-person evaluation before prescribing Schedule II-V controlled substances. But since March 2020, the DEA has continuously waived this requirement under public health emergency authority.
As of February 2026, that waiver remains in effect through December 31, 2025 (extended multiple times), meaning you can legally prescribe controlled substances to new patients via telehealth without ever seeing them in person (texasnp.org) (natlawreview.com).
However: The DEA has proposed new permanent rules that could reimpose some in-person requirements (possibly with exceptions like 30-day supply limits or referrals from in-person providers). While those rules haven’t been finalized, psychiatrists should stay alert for changes expected by late 2024 (www.nixonpeabody.com).
Practical reality: Most telepsychiatrists are currently managing ADHD, anxiety, and substance use disorders entirely online under these flexibilities. If you’re on a platform like Klarity Health, you’re operating within established federal allowances — just be ready to adapt if rules tighten.
Even with federal flexibility, some states have their own teleprescribing rules. Here’s how the major states break down:
Florida: One of the most permissive. Florida law explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (www.flsenate.gov). You can start a patient on Adderall or benzos via video visit. The only prohibition is prescribing opioids for chronic pain management via telehealth — not relevant for most psychiatric practice.
Texas: Generally allows telemedicine prescribing if the standard of care is met, but prohibits prescribing Schedule II controlled substances for chronic pain via telehealth (www.cchpca.org). Mental health treatment is exempt — a Texas psychiatrist can prescribe stimulants or benzos via telehealth for ADHD or anxiety, but would need an in-person visit to manage long-term opioid therapy for pain. Texas also requires checking the Prescription Monitoring Program (PMP) before any controlled substance prescription.
New York: Updated its rules in mid-2025 to align with federal allowances. New York now permits controlled substance prescribing via telehealth when consistent with DEA waivers (www.nixonpeabody.com). Prior confusion about state vs. federal requirements has been resolved. New York requires e-prescribing (no paper scripts) and mandatory PMP checks.
California: Requires a ‘good faith exam’ before prescribing, but telehealth evaluations satisfy this requirement (natlawreview.com). California defers to federal law on controlled substances, so the DEA waiver applies. You must be enrolled in CURES (California’s PMP) and check it at least every 4 months for ongoing therapy.
Pennsylvania and Illinois: Both follow federal telehealth rules for controlled substances. Pennsylvania requires PMP checks; Illinois requires NPs to have specific controlled substance registration, but MDs can prescribe under standard DEA authority.
You must be licensed in the state where the patient is physically located at the time of the visit. The Interstate Medical Licensure Compact (IMLC) helps — Texas, Pennsylvania, and Illinois are members, which expedites getting additional licenses. New York, Florida, and California are not in the compact, so you’ll go through the traditional process.
Some states offer ‘telehealth-only’ registrations for out-of-state providers, but these typically do not allow controlled substance prescribing. If you want to prescribe psychiatric medications (especially controlled substances) across state lines, get full licensure in those states.
This is where things get complicated — and where your practice structure needs to adapt based on state regulations.
As an MD or DO, you have independent prescribing authority everywhere. No supervision. No collaborative agreements. No scope limitations. You can prescribe any psychiatric medication, manage any condition, and operate solo in any state where you hold a license.
Psychiatric nurse practitioners face wildly different rules depending on state law. As of 2025, about 34 states grant NPs Full Practice Authority (FPA), meaning they can practice and prescribe independently without physician oversight (www.nursepractitioneronline.com). The rest require varying degrees of physician collaboration or supervision.
Here’s how it breaks down in the major markets:
California: Transitioning to independence. As of 2023, NPs with ≥3 years experience can practice in collaborative settings without direct physician supervision (‘103 NP’ certification). Starting January 2026, they can apply for full independence (‘104 NP’) to practice solo, including prescribing (www.rn.ca.gov). New PMHNPs still need physician protocols for their first three years.
Texas: Strictly restricted. PMHNPs cannot prescribe anything without a Prescriptive Authority Agreement with a Texas physician (www.bon.texas.gov). The physician must meet with the NP monthly for the first three years, then quarterly. Texas law also prohibits NPs from prescribing Schedule II controlled substances in outpatient settings except in very limited circumstances (www.cchpca.org). Practically, this means many Texas PMHNPs cannot independently prescribe ADHD stimulants — the supervising psychiatrist often writes those scripts.
Florida: Psychiatric NPs were excluded from the 2020 law that granted autonomous practice to primary care NPs (www.npschools.com). PMHNPs must practice under a supervising physician’s protocol. However, Florida defines ‘psychiatric nurse’ (PMHNP with 2+ years experience under a psychiatrist) who can prescribe psychotropic controlled substances without the usual 7-day Schedule II limit that applies to other NPs (www.flsenate.gov). The collaborating physician must be a psychiatrist for this designation.
New York: PMHNPs must initially practice under a physician’s written agreement for their first 3,600 hours (about 2 years). After that, they can practice fully independently without supervision or chart reviews (www.jdsupra.com). This makes New York effectively a full-practice state for experienced NPs.
Pennsylvania: Requires collaborative agreements indefinitely — no pathway to independence yet (www.pacnp.org). PMHNPs can prescribe Schedules II-V if delegated, but Schedule II prescriptions are limited to 30-day supply and require physician notification within 24 hours. The physician must review a portion of charts regularly.
Illinois: PMHNPs must complete 4,000 hours under physician collaboration plus 250 hours of continuing education before applying for Full Practice Authority (www.nursepractitionerlicense.com). Once granted, they can prescribe independently, including controlled substances (with their own mid-level controlled substance registration).
If you’re building a telepsychiatry practice across multiple states:
For a telehealth platform, this means the provider mix and supervision structure must flex state by state. Klarity Health handles this by credentialing providers appropriately in each state and ensuring compliance with local collaborative practice requirements where needed.
Let’s talk economics. Psychiatrists bill medication management visits using standard Evaluation & Management (E/M) codes:
Private insurance typically pays higher than Medicare — often $150-200 for a 99213 and $200-250 for a 99214 in major markets.
The good news: most states now require equal reimbursement for telehealth vs. in-person mental health services. Medicare has permanently allowed telehealth for behavioral health (with a nominal requirement for periodic in-person visits that’s been repeatedly waived). States like California, Illinois, and New York have codified payment parity into law (natlawreview.com).
Texas doesn’t mandate parity, but most insurers pay it voluntarily given demand. Florida similarly lacks a mandate, but behavioral health reimbursement is generally equivalent.
Bottom line: You can bill a video visit the same as an office visit. Use the appropriate place-of-service code (POS-02 for telehealth) or modifier (95), and you’re covered.
Here’s where many psychiatrists get tripped up when evaluating practice models.
DIY marketing — whether through SEO, Google Ads, or directory listings — is expensive and time-consuming.
Let’s be honest about the real costs:
SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You’re paying an agency or consultant $2,000-5,000/month with no guaranteed results for the first half-year. Most solo providers don’t have the expertise or patience.
Google Ads for mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ once you factor in ad spend, testing, optimization, and lead qualification.
Directory listings like Psychology Today or Zocdoc charge monthly subscription fees ($30-50/month for PT, higher for Zocdoc), and you’re competing with hundreds of other providers on the same page. Zocdoc also charges per booking ($35-100+ per new patient). When you add it all up — monthly subscription + per-booking fees + staff time to handle inquiries + no-show rates from cold leads — your effective cost per established patient is easily $200-500+.
Total DIY cost: If you’re spending $3,000-5,000/month on marketing across SEO, ads, and directories, and you acquire 10-20 new patients per month, you’re paying $150-500 per patient acquisition — before accounting for no-shows and patients who don’t stick.
That’s the gamble: You pay upfront with no guarantee of ROI.
Klarity Health uses a pay-per-appointment model similar to Zocdoc, but with a critical difference: the patients are pre-qualified and matched to your specialty and availability.
Here’s the value proposition:
Instead of gambling $3,000-5,000/month on marketing channels with uncertain results, you pay a standard listing fee per new patient appointment. That’s guaranteed ROI — if the patient doesn’t show, you don’t pay. If the patient books and shows, you pay once and start generating revenue immediately.
For a psychiatrist billing $150-200 for a 15-minute med check, a per-appointment listing fee is a fraction of the visit revenue — and every subsequent appointment with that patient is pure profit.
This is especially valuable for:
The alternative — spending months building SEO rankings, testing ad campaigns, and negotiating directory placements — works if you have the budget, expertise, and patience. But for most providers, platforms that handle patient acquisition remove the risk entirely.
Mental health provider shortages vary significantly by state, affecting both opportunity and reimbursement dynamics:
Texas and Florida: Among the worst psychiatrist-to-population ratios nationally (~1:8,500-9,000 residents) (www.healingpsychiatryflorida.com). High demand means ample telehealth patient volume, but Texas’s restrictive NP laws limit practice flexibility.
California: Better ratio (~1:5,000-5,800) but over 11 million Californians live in Mental Health Professional Shortage Areas (www.healingpsychiatryflorida.com). The state is actively expanding NP autonomy to address this.
New York: High concentration in NYC (~1:2,900 statewide) but upstate regions remain severely underserved. The state has ~197 mental health HPSAs needing ~230 additional psychiatrists (www.healingpsychiatryflorida.com).
Pennsylvania: Mid-ranked density (1:4,586 residents) with rural gaps (www.healingpsychiatryflorida.com). Still requires NP collaboration, limiting independent NP practice growth.
Illinois: Similar to Pennsylvania (~1:5,000-6,000), with significant rural shortages. The state needs ~291 additional practitioners to eliminate Mental Health Professional Shortage Areas (www.healingpsychiatryflorida.com).
These conditions translate to strong patient demand for telehealth psychiatric services — especially for ADHD, anxiety, and depression management where medications are core to treatment.
Beyond prescribing authority, here are the regulatory requirements that trip up telepsychiatrists:
Prescription Monitoring Programs (PMPs): Most states require checking the PMP before prescribing controlled substances. Texas, Florida, California, New York, Pennsylvania, and Illinois all mandate this. Some require it before every controlled substance prescription; others allow checking periodically (e.g., every 4 months in California).
E-Prescribing Requirements: New York requires e-prescribing for all prescriptions (no paper scripts for controlled substances). Many states encourage or require EPCS (Electronic Prescribing of Controlled Substances) with two-factor authentication.
Documentation Standards: Telehealth notes must document the same elements as in-person visits — including mental status exam, treatment rationale, and medication changes. Many states require documenting that the visit was via telehealth, the patient’s location, and consent for telehealth treatment.
Emergency Protocols: Some states (like Texas) require telepsychiatry practices to have documented protocols for patient emergencies — what happens if a suicidal patient disconnects mid-session (www.cchpca.org).
Informed Consent: California and Texas explicitly require informing patients of telehealth limitations and obtaining documented consent. This should cover privacy, technology limitations, and emergency procedures.
Standard of Care: The telehealth evaluation must meet the same standard as an in-person exam. This typically means video (not just phone) for initial evaluations when prescribing controlled substances — though some states and Medicare now reimburse audio-only visits for established mental health patients.
Can I prescribe Adderall or other stimulants to a new patient via telehealth without ever meeting them in person?
Yes, under current federal DEA waivers extending through December 31, 2025. After that, new permanent rules may apply, but for now, psychiatrists can initiate ADHD stimulant treatment entirely via video visit (texasnp.org) (natlawreview.com).
Do I need a DEA license in every state where I see patients via telehealth?
You need one DEA registration (typically in your primary practice state), but you must comply with each state’s controlled substance laws where the patient is located. Some states require registering with their state’s controlled substance database or obtaining a state-level prescriber ID.
Can PMHNPs prescribe the same medications as psychiatrists?
In full-practice states (or after meeting transition requirements in states like New York or Illinois), yes. In restricted states like Texas, Florida, or Pennsylvania, PMHNPs have limitations — they may need physician co-signatures, face formulary restrictions, or be prohibited from prescribing certain Schedule II drugs.
How does reimbursement for telehealth compare to in-person visits?
Medicare and most state Medicaid programs now reimburse telehealth mental health services at parity with in-person. Private insurers in states with parity laws (California, Illinois, New York) must pay equally. Even in states without mandates (Texas, Florida), most payers voluntarily match in-person rates for behavioral health.
What happens if DEA rules change and reimpose in-person requirements?
The DEA has proposed allowing exceptions for 30-day supply limits, referrals from in-person providers, or special telehealth registrations. If permanent rules require periodic in-person visits, platforms like Klarity can help coordinate local partnerships or hybrid models. Most experts expect mental health to receive more flexible treatment than pain management given the access crisis.
What’s the difference between practicing on a platform like Klarity vs. building my own telehealth practice?
Building your own practice means handling marketing, credentialing, EHR setup, billing, and patient acquisition — with upfront costs of $3,000-5,000+/month and 6-12 months before ROI. Platforms provide instant patient flow, pre-built infrastructure, and pay-per-appointment economics that remove the financial risk. The trade-off is less control over branding and patient relationships, but significantly faster time-to-revenue and predictable economics.
Can I prescribe buprenorphine (Suboxone) via telehealth?
Yes. The X-waiver requirement was eliminated in 2023, so any DEA-licensed practitioner can prescribe buprenorphine. Telehealth prescribing of buprenorphine for opioid use disorder is explicitly allowed under the current DEA waivers and was even expanded during COVID to improve access.
Do I need malpractice insurance that covers telehealth?
Yes. Most malpractice carriers now cover telehealth, but verify your policy explicitly includes telemedicine. Some require notification if you’re practicing across state lines. Platforms like Klarity often provide guidance on recommended coverage levels.
Psychiatrists have broad authority to prescribe medications via telehealth in 2026, including controlled substances, thanks to federal flexibilities and state-level support for behavioral health access. The regulatory landscape varies by state — especially for PMHNPs — but the overall trend is toward expansion and parity.
Key takeaways:
Psychiatrists (MD/DO) have full prescribing authority everywhere they’re licensed; PMHNPs face state-specific restrictions ranging from full independence (NY, CA by 2026, IL after transition) to strict supervision (TX, FL, PA)
Federal DEA waivers currently allow teleprescribing of controlled substances without in-person exams through at least December 2025; stay alert for permanent rule changes
State variations matter: Florida explicitly allows psychiatric controlled substance prescribing via telehealth; Texas prohibits it for chronic pain but allows mental health treatment; New York and California align with federal rules
Reimbursement is favorable: Medicare pays $95-136 for typical med management follow-ups, with private insurance often higher; telehealth parity is now standard for behavioral health in most markets
Economics of patient acquisition: DIY marketing costs $200-500+ per qualified patient when you account for all expenses and time; platform models like Klarity’s pay-per-appointment structure remove upfront risk and guarantee ROI
Market opportunity is massive: States like Texas, Florida, California, and Illinois face severe psychiatrist shortages with millions in Mental Health Professional Shortage Areas — telehealth is the primary solution
If you’re ready to practice telepsychiatry without gambling on marketing ROI or navigating multi-state compliance solo, platforms that handle patient acquisition, credentialing, and infrastructure let you focus on what you do best: treating patients.
Ready to explore how Klarity Health can connect you with qualified patients in your licensed states? Join our provider network to see how pay-per-appointment economics and built-in telehealth infrastructure compare to the alternative of building a practice from scratch.
| Source & URL | Type of Source | Published/Updated | Reliability |
|---|---|---|---|
| California Board of Registered Nursing – AB 890 FAQs (www.rn.ca.gov) | Official state regulatory board website | Updated Nov 2023 | High – Primary source on CA NP scope |
| Texas Board of Nursing – APRN Practice FAQ (www.bon.texas.gov) | Official state board FAQ | Revised 2021 | High – Primary for TX NP rules |
| Zivian Health ‘2026 NP-Physician Collaboration Roadmap’ (www.zivianhealth.com) | Industry compliance blog | Feb 16, 2026 | Medium – Detailed overview aligns with state statutes |
| NursePractitionerLicense.com – Illinois NP limitations (www.nursepractitionerlicense.com) | Educational portal | Updated Feb 12, 2024 | Medium – Consolidates state law |
| JDSupra Law News – NY NP Independence Article (www.jdsupra.com) | Law firm article | April 13, 2022 | High – Cites NY Education Law changes |
| Florida Statutes Chapter 464 & 456 (www.flsenate.gov) | Official state statutes | 2024 compilation | High – Primary legal text |
| Pennsylvania Coalition of Nurse Practitioners (www.pacnp.org) | Professional association | Updated 2022 | Medium – Accurate reflection of PA law |
| NursePractitionerOnline.com – NP Practice Authority 2026 (www.nursepractitioneronline.com) | Professional article | Last verified Feb 5, 2026 | Medium – Provides overall trends |
| Center for Connected Health Policy – Texas Telehealth Laws (www.cchpca.org) | Non-profit policy org | Updated Jan 19, 2026 | High – Comprehensive telehealth database |
| National Law Review – Telehealth Prescribing Update (natlawreview.com) | Legal news | Aug 15, 2025 | High – Healthcare attorney analysis |
| Nixon Peabody Client Alert – NY telemedicine rule (www.nixonpeabody.com) | Law firm alert | June 18, 2025 | High – Expert interpretation |
| Texas Nurse Practitioners Assoc. – DEA Extension (texasnp.org) | Professional association | Oct 6, 2023 | High – Cites federal announcements |
| TheraThink – Insurance Reimbursement Rates 2026 (therathink.com) | Medical billing service blog | 2026 rates | Medium – Uses CMS data |
| Healing Psychiatry Florida – Psychiatrist Shortage by State (www.healingpsychiatryflorida.com) | Healthcare blog | Jan 15, 2026 | Medium – Quotes HRSA stats |
| NCSL – Scope of Practice 2024 |
Find the right provider for your needs — select your state to find expert care near you.